Mankind Pharma Ltd. - Research Center
543904 MANKIND Group (B) BSE data
Results
|
Half yearly
|
Statement
|
|
More
|
|
Half yearly results in brief
(Rs crore)
|
Sep ' 23 |
Sep ' 22 |
Sales |
4,753.56 |
4,318.80 |
Operating profit |
1,174.66 |
942.72 |
Interest |
6.28 |
17.62 |
Gross profit |
1,283.94 |
1,013.03 |
EPS (Rs) |
22.02 |
17.93 |
Half yearly
results in details
|
Sep ' 23 |
Sep ' 22 |
Other income |
115.55 |
87.92 |
Stock adjustment |
17.83 |
218.14 |
Raw material |
443.38 |
385.72 |
Power and fuel |
- |
- |
Employee expenses |
981.49 |
849.83 |
Excise |
- |
- |
Admin and selling expenses |
- |
- |
Research and development expenses |
- |
- |
Expenses capitalised |
- |
- |
Other expenses |
2,136.19 |
1,922.39 |
Provisions made |
- |
- |
Depreciation |
145.58 |
131.26 |
Taxation |
256.19 |
163.37 |
Net profit / loss |
882.17 |
718.40 |
Extra ordinary item |
- |
- |
Prior year adjustments |
- |
- |
Equity capital |
40.06 |
40.06 |
Equity dividend rate |
- |
- |
Agg.of non-prom. shares (Lacs) |
- |
- |
Agg.of non promotoholding (%) |
- |
- |
OPM (%) |
24.71 |
21.83 |
GPM (%) |
26.37 |
22.99 |
NPM (%) |
18.12 |
16.30 |